81 related articles for article (PubMed ID: 21212738)
41. Checking in on hypoxia/reoxygenation.
Freiberg RA; Krieg AJ; Giaccia AJ; Hammond EM
Cell Cycle; 2006 Jun; 5(12):1304-7. PubMed ID: 16760660
[TBL] [Abstract][Full Text] [Related]
42. Phosphorylation of p53 is regulated by TPX2-Aurora A in xenopus oocytes.
Pascreau G; Eckerdt F; Lewellyn AL; Prigent C; Maller JL
J Biol Chem; 2009 Feb; 284(9):5497-505. PubMed ID: 19121998
[TBL] [Abstract][Full Text] [Related]
43. Constitutive phosphorylation of ATM in lymphoblastoid cell lines from patients with ICF syndrome without downstream kinase activity.
Goldstine JV; Nahas S; Gamo K; Gartler SM; Hansen RS; Roelfsema JH; Gatti RA; Marahrens Y
DNA Repair (Amst); 2006 Apr; 5(4):432-43. PubMed ID: 16426903
[TBL] [Abstract][Full Text] [Related]
44. Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1.
Yoon JH; Ahn SG; Lee BH; Jung SH; Oh SH
Biochem Pharmacol; 2012 Mar; 83(6):747-57. PubMed ID: 22226932
[TBL] [Abstract][Full Text] [Related]
45. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53.
Canman CE; Lim DS; Cimprich KA; Taya Y; Tamai K; Sakaguchi K; Appella E; Kastan MB; Siliciano JD
Science; 1998 Sep; 281(5383):1677-9. PubMed ID: 9733515
[TBL] [Abstract][Full Text] [Related]
46. Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex.
Lee JH; Paull TT
Science; 2004 Apr; 304(5667):93-6. PubMed ID: 15064416
[TBL] [Abstract][Full Text] [Related]
47. STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage.
Townsend PA; Cragg MS; Davidson SM; McCormick J; Barry S; Lawrence KM; Knight RA; Hubank M; Chen PL; Latchman DS; Stephanou A
J Cell Sci; 2005 Apr; 118(Pt 8):1629-39. PubMed ID: 15784679
[TBL] [Abstract][Full Text] [Related]
48. [Effect of papillary thyroid carcinoma related gene PTC1 on subcellular localization and function of ATM cell].
Tie Y; Mao JP; Liu B; Song Y; Dong Y; Sun ZX
Ai Zheng; 2004 May; 23(5):487-92. PubMed ID: 15142440
[TBL] [Abstract][Full Text] [Related]
49. Hsp90 inhibition has opposing effects on wild-type and mutant p53 and induces p21 expression and cytotoxicity irrespective of p53/ATM status in chronic lymphocytic leukaemia cells.
Lin K; Rockliffe N; Johnson GG; Sherrington PD; Pettitt AR
Oncogene; 2008 Apr; 27(17):2445-55. PubMed ID: 17982489
[TBL] [Abstract][Full Text] [Related]
50. [Interaction between ATM and radiation-activated phosphorylation of P53 and P21].
Luo JL; Cao JP; Zhu W; Feng S; Sheng FJ; Zhu CY; Zheng SY
Ai Zheng; 2005 Sep; 24(9):1059-63. PubMed ID: 16159425
[TBL] [Abstract][Full Text] [Related]
51. Polycomb group proteins: New targets of anti-cancer therapy.
Kang MK
Cell Cycle; 2010 Jul; 9(14):2704. PubMed ID: 20676028
[No Abstract] [Full Text] [Related]
52. Effects of EDD on p53 function are context-specific.
Watts CK; Saunders DN
J Biol Chem; 2011 Jul; 286(28):le13; author reply le14. PubMed ID: 21757764
[No Abstract] [Full Text] [Related]
53. Aurora B kinase phosphorylates and instigates degradation of p53.
Gully CP; Velazquez-Torres G; Shin JH; Fuentes-Mattei E; Wang E; Carlock C; Chen J; Rothenberg D; Adams HP; Choi HH; Guma S; Phan L; Chou PC; Su CH; Zhang F; Chen JS; Yang TY; Yeung SC; Lee MH
Proc Natl Acad Sci U S A; 2012 Jun; 109(24):E1513-22. PubMed ID: 22611192
[TBL] [Abstract][Full Text] [Related]
54. Chromosome ends teach unexpected lessons on DNA damage signalling.
Chang S
EMBO J; 2012 Aug; 31(16):3380-1. PubMed ID: 22842787
[TBL] [Abstract][Full Text] [Related]
55. Variation in DNA damage response pathway activity: focus on intermediate phenotype instead of genetic polymorphisms.
van Heemst D
Cell Cycle; 2011 Jun; 10(11):1714. PubMed ID: 21537112
[No Abstract] [Full Text] [Related]
56. The dark side of the oxidative force in angiogenesis.
Kerr BA; Byzova TV
Nat Med; 2012 Aug; 18(8):1184-5. PubMed ID: 22869186
[No Abstract] [Full Text] [Related]
57. Aurora A mediates cross-talk between N- and C-terminal post-translational modifications of p53.
Warnock LJ; Raines SA; Milner J
Cancer Biol Ther; 2011 Dec; 12(12):1059-68. PubMed ID: 22157150
[TBL] [Abstract][Full Text] [Related]
58. Compensation, crosstalk and sequestering: the currency of checkpoints in cancer.
Kaufmann WK; Anderson CW
Cell Cycle; 2013 Apr; 12(8):1163-4. PubMed ID: 23549170
[No Abstract] [Full Text] [Related]
59. p53-Aurora A mitotic feedback loop regulates cell cycle progression and genomic stability.
Chiang CM
Cell Cycle; 2012 Oct; 11(20):3719-20. PubMed ID: 22982999
[No Abstract] [Full Text] [Related]
60. Micromanaging a large tumor suppressor.
Li Y; Spaner DE
Cell Cycle; 2012 Dec; 11(24):4497. PubMed ID: 23222067
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
